Professional Documents
Culture Documents
Dr Amit Rangnekar
Head to Head
Estd
Sales
Fabindia
1958
3bn
Faze3
1985
2bn
Operations
India
US / EU 100% EOU
Status
Segments
Closely Held
Garments, Furnishing,
Organics, Body care
Listed
Home furnishing
Target
Range
Key driver
Global consumers
Full price range
Integrated facilities,
wide range, global
acceptance
Head to Head
Fabindia
Faze3
Management
bandwidth
Local
Global, in place
Customers /
Clients
US & EU Retail
majors
Area of
expansion
Retail reach
Facilities
85 own outlets
None, outsourced
Capabilities
Local
World Class
Value Chain
Unintegrated
Fabindia
22,000
Weavers
&
Artisans
Fabricators
Value
Garments,
Furnishings,
Organics &
Body care
Own
85
Outlets
Integrated
Faze3
Integrated
Factories
Focus on
Furnishings
Value
Retail Majors
Retailers
Outlets
New
Existing
Market Development
New
Products
Market Penetration
Faze 3
Diversification
SWOT
S
Integrated facilities
Global acceptance
Full range
Design proficiencies
O
Allied segments
Build brand Faze 3
Retail presence
Penetrate EU / US
W
Emerging markets
presence
T
Weak $
Rising input costs
Regulatory
Gap Analysis
Desired Goal
er
v
i
D
n
o
i
t
a
c
i
f
si
Int
Strategic
Planning
Gap
e
v
i
t
a
egr
Sales
e
Intensiv
Current Portfolio
Period
Carpets
Rubber
Mats
Rugs
Door Mats
Printed
Rugs
Bath
Tuffed
Cushions
Dyeing
Curtains
Sofa
Kitchen
In Place
Future
Value adds
Brand, Allied
New Segments
Trade up / down
New Geographies
Emerging markets
M&A
EU
Scale / Scope
Strategic Alliances
Retail, technology,
manufacturing
Related
Diversification
Capacities
India / EU
Cost leadership,
Outsourcing
Forward Integration
Faze3
Retail Outlets
Faze3
Majors
Retail Majors
Faze3
PANA
Manufacture
Inputs ?
Trade
M&A
Competitor
Manufacturing
Inputs
Backward Integration
Horizontal Integration
Yarn Trade
Polyester Manufacture
5
IPCL
Petrochemical
Refineries
Gas
Infocom
9
Retail
CE Marketing
CE Manufacture
TV Tubes
Silica
Oil
FMCG 8%
Lifestyle Retail
Personal Care
e-Choupal
Agri-Biz 18%
Foods
Greetings
IT
Staples
Biscuits
Matches
Snacks
Agarbattis
Finance
2.5 mn
retailers
Hotels 5%
Cigarettes 59%
Paper 10%
Confectionery
Ready to Eat
Pharma Strategy
M&A+S
A+
Organi
c
Strateg
y
Followe
rs
Stayer
s
Fringers
Ranbaxy
DrReddys
Surviv
ors
Pfize
GSK r
SanofiAventis
Roche
Novartis
BMS
AstraZeneca
UCB
Pliva
Organi
c
SA+
Organi
c
B Ingelheim
J&J
ScheringPlough
Cipla
NovoNordisk
EliLilly
Beijing DCLundbeck Baye
Natc
Merck(US)
o
ViPharm
Aurobindo
r
Wyeth
Merck(Ger)
Taro
AkzoNobel
BlueCross
<$1 Bn
<$5 Bn
Scale
<$20
Bn
>$20
Bn
Strategy Square
Conditions
Competition
Consumer
Corporation
(Faze3)
Costs
Economies
Integration
Design
Fabindia
Faze 3
Substitutes
Technology
New fabrics
Retail
Brand
Buyers
Own outlets
Local majors
Global majors
18
Suppliers
Reliance
Du Pont
Duopoly
Essel,
Flex
Buyers
HUL
Nestle
P&G
Substitutes
Tie-ups
Buy Tech
19
Quality &
delivery
Global
Retail
Majors
7 Integrated
Plants
Manufacturing
Prowess
Design
Capabilities
Full Range
Segment focus
Innovation
20
Challenge
Capture value?
Deliver value to stake holders
g
n
Lo
rm
e
T
Mi
rm
e
dT
rm
e
T
t
Shor
Capture
Value
Instant
Brand
India / Retail
Penetrate US / UK
/ New segments
High
Medium
Low
Competitive position
Business Position
Low
Medium
High
Product/market attractiveness
Strategic Options
Ally
Diversify
Buy
Build
Where to compete
24
Potential
Served
Unarticulated
Needs
Articulated
Needs
Faze3
Today
Unserved
Branding Decisions
Targeting
Which Product for which market
Single
segment
Single
market
Single
product segment
Selective
segments
Entire
Market
Overlooked
Known
Unacceptable
Indifferent
Not Prescribed
Acceptable
Prescribed
Faze3
Anticipation of strategies
Action
Aggressive offense
Aggressive defense
Slow defensive response
Cut price to attack / defend
Increase promotion
Comp1
Comp2
Comp3 Faze3
Fabindia
Faze3
Platform in
place
Time to take-off
Retail thrust
Penetrate
through own
retail
Aggregate
supply chain
Key
Acceptance
Internalisation
Execution